Skip to main content
Top
Published in: International Cancer Conference Journal 3/2015

01-07-2015 | Case report

HCC without cirrhosis metastasizing to the clivus

Authors: Wesley Yung-Hsu Yu, Lawrence M. Tierney Jr.

Published in: International Cancer Conference Journal | Issue 3/2015

Login to get access

Abstract

The initial presentation of hepatocellular carcinoma (HCC) as a cranial nerve palsy is exceedingly rare. A lack of cirrhosis and elevated AFP in metastatic HCC is also uncommon. To our knowledge, this is the first case report of HCC presenting with ageusia without prior evidence of liver pathology. A 65-year-old man was admitted to our hospital for dysphagia. Over months, he had noticed 36 kg weight loss, dysphagia, ageusia, and horizontal diplopia. He had a low AFP, no evidence of cirrhosis, and no symptoms of liver pathology. On brain magnetic resonance imaging, he was found to have a mass in the clivus. On biopsy, metastatic HCC was diagnosed. HCC can be fatal if not recognized early. It rarely causes neurologic complications through metastasis to the skull. It is important to understand the localization of lesions to the clivus and include internal malignancy in creating a differential for cases of neurologic complaint.
Literature
1.
go back to reference Grando-lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC (1999) Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol 31(3):508–513PubMedCrossRef Grando-lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC (1999) Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol 31(3):508–513PubMedCrossRef
2.
go back to reference Chalasani N, Horlander JC, Said A et al (1999) Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 94(10):2988–2993PubMedCrossRef Chalasani N, Horlander JC, Said A et al (1999) Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 94(10):2988–2993PubMedCrossRef
3.
go back to reference Melia WM, Wilkinson ML, Portmann BC, Johnson PJ, Williams R (1984) Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med 53(211):391–400PubMed Melia WM, Wilkinson ML, Portmann BC, Johnson PJ, Williams R (1984) Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med 53(211):391–400PubMed
4.
go back to reference Laigle-donadey F, Taillibert S, Martin-duverneuil N, Hildebrand J, Delattre JY (2005) Skull-base metastases. J Neurooncol 75(1):63–69PubMedCrossRef Laigle-donadey F, Taillibert S, Martin-duverneuil N, Hildebrand J, Delattre JY (2005) Skull-base metastases. J Neurooncol 75(1):63–69PubMedCrossRef
5.
go back to reference Hsieh CT, Sun JM, Tsai WC, Tsai TH, Chiang YH, Liu MY (2007) Skull metastasis from hepatocellular carcinoma. Acta Neurochir (Wien) 149(2):185–190CrossRef Hsieh CT, Sun JM, Tsai WC, Tsai TH, Chiang YH, Liu MY (2007) Skull metastasis from hepatocellular carcinoma. Acta Neurochir (Wien) 149(2):185–190CrossRef
6.
go back to reference Brunt EM (2012) Histopathologic features of hepatocellular carcinoma. Clin Liv Dis 1(6):194–199CrossRef Brunt EM (2012) Histopathologic features of hepatocellular carcinoma. Clin Liv Dis 1(6):194–199CrossRef
Metadata
Title
HCC without cirrhosis metastasizing to the clivus
Authors
Wesley Yung-Hsu Yu
Lawrence M. Tierney Jr.
Publication date
01-07-2015
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 3/2015
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-014-0195-1

Other articles of this Issue 3/2015

International Cancer Conference Journal 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine